MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

Search

DexCom Inc

Abrir

SetorSaúde

71.79 1.47

Visão Geral

Variação de preço das ações

24h

Atual

Mín

69.85

Máximo

72.23

Indicadores-chave

By Trading Economics

Rendimento

17M

152M

Vendas

119M

1.1B

P/E

Médio do Setor

46.556

57.333

EPS

0.45

Margem de lucro

13.624

Funcionários

10,200

EBITDA

5M

242M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+41.2% upside

Dividendos

By Dow Jones

Próximos Ganhos

1 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-8.4B

26B

Abertura anterior

70.32

Fecho anterior

71.79

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

DexCom Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de out. de 2024, 09:10 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 de jul. de 2024, 20:16 UTC

Ganhos

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 de jul. de 2024, 09:13 UTC

Principais Notícias
Ações em Alta

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 de jul. de 2024, 08:56 UTC

Principais Notícias

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 de jun. de 2024, 16:01 UTC

Ganhos

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparação entre Pares

Variação de preço

DexCom Inc Previsão

Preço-alvo

By TipRanks

41.2% parte superior

Previsão para 12 meses

Média 99.94 USD  41.2%

Máximo 115 USD

Mínimo 82 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para DexCom Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

19 ratings

17

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

66.46 / 73.5Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Very Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.